Although ideally it might be expected that leptin acts as a true ‘anti-obesity’ hormone promoting satiety, reducing food intake and increasing energy expenditure (Myers et al., 2010), its ability to modulate adiposity can be forestalled by perturbations in the activation of the signalling pathway, often characterised by hyperleptinemia. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.